Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20852643rdf:typepubmed:Citationlld:pubmed
pubmed-article:20852643lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:20852643lifeskim:mentionsumls-concept:C0043474lld:lifeskim
pubmed-article:20852643lifeskim:mentionsumls-concept:C0728940lld:lifeskim
pubmed-article:20852643lifeskim:mentionsumls-concept:C0683598lld:lifeskim
pubmed-article:20852643lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:20852643lifeskim:mentionsumls-concept:C1527178lld:lifeskim
pubmed-article:20852643pubmed:issue10lld:pubmed
pubmed-article:20852643pubmed:dateCreated2010-10-6lld:pubmed
pubmed-article:20852643pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852643pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852643pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852643pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852643pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852643pubmed:abstractTextHuman immunodeficiency virus (HIV-1) develops resistance to 3'-azido-2',3'-deoxythymidine (AZT, zidovudine) by acquiring mutations in reverse transcriptase that enhance the ATP-mediated excision of AZT monophosphate from the 3' end of the primer. The excision reaction occurs at the dNTP-binding site, uses ATP as a pyrophosphate donor, unblocks the primer terminus and allows reverse transcriptase to continue viral DNA synthesis. The excision product is AZT adenosine dinucleoside tetraphosphate (AZTppppA). We determined five crystal structures: wild-type reverse transcriptase-double-stranded DNA (RT-dsDNA)-AZTppppA; AZT-resistant (AZTr; M41L D67N K70R T215Y K219Q) RT-dsDNA-AZTppppA; AZTr RT-dsDNA terminated with AZT at dNTP- and primer-binding sites; and AZTr apo reverse transcriptase. The AMP part of AZTppppA bound differently to wild-type and AZTr reverse transcriptases, whereas the AZT triphosphate part bound the two enzymes similarly. Thus, the resistance mutations create a high-affinity ATP-binding site. The structure of the site provides an opportunity to design inhibitors of AZT-monophosphate excision.lld:pubmed
pubmed-article:20852643pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852643pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852643pubmed:languageenglld:pubmed
pubmed-article:20852643pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852643pubmed:citationSubsetIMlld:pubmed
pubmed-article:20852643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852643pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20852643pubmed:statusMEDLINElld:pubmed
pubmed-article:20852643pubmed:monthOctlld:pubmed
pubmed-article:20852643pubmed:issn1545-9985lld:pubmed
pubmed-article:20852643pubmed:authorpubmed-author:HughesStephen...lld:pubmed
pubmed-article:20852643pubmed:authorpubmed-author:DasKalyanKlld:pubmed
pubmed-article:20852643pubmed:authorpubmed-author:ArnoldEddyElld:pubmed
pubmed-article:20852643pubmed:authorpubmed-author:BoyerPaul LPLlld:pubmed
pubmed-article:20852643pubmed:authorpubmed-author:SarafianosSte...lld:pubmed
pubmed-article:20852643pubmed:authorpubmed-author:TuXiongyingXlld:pubmed
pubmed-article:20852643pubmed:authorpubmed-author:JonesRoger...lld:pubmed
pubmed-article:20852643pubmed:authorpubmed-author:BaumanJoseph...lld:pubmed
pubmed-article:20852643pubmed:authorpubmed-author:ClarkArthur...lld:pubmed
pubmed-article:20852643pubmed:authorpubmed-author:GaffneyBarbar...lld:pubmed
pubmed-article:20852643pubmed:authorpubmed-author:HouXiaorongXlld:pubmed
pubmed-article:20852643pubmed:authorpubmed-author:HanQianweiQlld:pubmed
pubmed-article:20852643pubmed:authorpubmed-author:FrenkelYulia...lld:pubmed
pubmed-article:20852643pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20852643pubmed:volume17lld:pubmed
pubmed-article:20852643pubmed:ownerNLMlld:pubmed
pubmed-article:20852643pubmed:authorsCompleteYlld:pubmed
pubmed-article:20852643pubmed:pagination1202-9lld:pubmed
pubmed-article:20852643pubmed:dateRevised2010-12-3lld:pubmed
pubmed-article:20852643pubmed:meshHeadingpubmed-meshheading:20852643...lld:pubmed
pubmed-article:20852643pubmed:meshHeadingpubmed-meshheading:20852643...lld:pubmed
pubmed-article:20852643pubmed:meshHeadingpubmed-meshheading:20852643...lld:pubmed
pubmed-article:20852643pubmed:meshHeadingpubmed-meshheading:20852643...lld:pubmed
pubmed-article:20852643pubmed:meshHeadingpubmed-meshheading:20852643...lld:pubmed
pubmed-article:20852643pubmed:meshHeadingpubmed-meshheading:20852643...lld:pubmed
pubmed-article:20852643pubmed:meshHeadingpubmed-meshheading:20852643...lld:pubmed
pubmed-article:20852643pubmed:meshHeadingpubmed-meshheading:20852643...lld:pubmed
pubmed-article:20852643pubmed:meshHeadingpubmed-meshheading:20852643...lld:pubmed
pubmed-article:20852643pubmed:meshHeadingpubmed-meshheading:20852643...lld:pubmed
pubmed-article:20852643pubmed:meshHeadingpubmed-meshheading:20852643...lld:pubmed
pubmed-article:20852643pubmed:meshHeadingpubmed-meshheading:20852643...lld:pubmed
pubmed-article:20852643pubmed:meshHeadingpubmed-meshheading:20852643...lld:pubmed
pubmed-article:20852643pubmed:meshHeadingpubmed-meshheading:20852643...lld:pubmed
pubmed-article:20852643pubmed:meshHeadingpubmed-meshheading:20852643...lld:pubmed
pubmed-article:20852643pubmed:meshHeadingpubmed-meshheading:20852643...lld:pubmed
pubmed-article:20852643pubmed:meshHeadingpubmed-meshheading:20852643...lld:pubmed
pubmed-article:20852643pubmed:meshHeadingpubmed-meshheading:20852643...lld:pubmed
pubmed-article:20852643pubmed:meshHeadingpubmed-meshheading:20852643...lld:pubmed
pubmed-article:20852643pubmed:meshHeadingpubmed-meshheading:20852643...lld:pubmed
pubmed-article:20852643pubmed:year2010lld:pubmed
pubmed-article:20852643pubmed:articleTitleStructural basis of HIV-1 resistance to AZT by excision.lld:pubmed
pubmed-article:20852643pubmed:affiliationCenter for Advanced Biotechnology and Medicine, Piscataway, New Jersey, USA.lld:pubmed
pubmed-article:20852643pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20852643lld:pubmed